首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   11919篇
  免费   1645篇
  国内免费   178篇
耳鼻咽喉   34篇
儿科学   329篇
妇产科学   100篇
基础医学   785篇
口腔科学   98篇
临床医学   797篇
内科学   1187篇
皮肤病学   206篇
神经病学   350篇
特种医学   1825篇
外国民族医学   9篇
外科学   587篇
综合类   1306篇
现状与发展   2篇
预防医学   1526篇
眼科学   72篇
药学   2476篇
  16篇
中国医学   305篇
肿瘤学   1732篇
  2024年   18篇
  2023年   217篇
  2022年   307篇
  2021年   502篇
  2020年   512篇
  2019年   470篇
  2018年   553篇
  2017年   519篇
  2016年   507篇
  2015年   448篇
  2014年   951篇
  2013年   1048篇
  2012年   781篇
  2011年   830篇
  2010年   624篇
  2009年   565篇
  2008年   600篇
  2007年   524篇
  2006年   432篇
  2005年   360篇
  2004年   307篇
  2003年   272篇
  2002年   252篇
  2001年   227篇
  2000年   193篇
  1999年   170篇
  1998年   135篇
  1997年   140篇
  1996年   102篇
  1995年   109篇
  1994年   95篇
  1993年   100篇
  1992年   66篇
  1991年   74篇
  1990年   69篇
  1989年   82篇
  1988年   67篇
  1987年   56篇
  1986年   51篇
  1985年   80篇
  1984年   63篇
  1983年   35篇
  1982年   54篇
  1981年   41篇
  1980年   37篇
  1979年   37篇
  1978年   8篇
  1977年   21篇
  1976年   9篇
  1975年   7篇
排序方式: 共有10000条查询结果,搜索用时 984 毫秒
51.
Leningrad University. (Presented by Academician of the Academy of Medical Sciences of the USSR S. N. Golikov.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 111, No. 5, pp. 458–460, May, 1991.  相似文献   
52.
The in-vitro oestradiol (E2) and progesterone (P) production by corpora lutea (CL) obtained at sterilization from 30 untreated women and 43 women treated with norethisterone (NET) 300 micrograms daily was measured. The CL were obtained at different stages of the luteal phase in the untreated women [luteinizing hormone (LH) 0 to +3, n = 7; LH +4 to +7, n = 7; LH +8 to +11, n = 9; LH +12 to menses, n = 7] and on days LH +8 to +11 or cycle days 22 to 26 in the NET-treated women. In the treated women, four types of ovarian reaction were identified. Four women showed ovarian reaction Type A (completely inhibited ovarian activity), 14 women Type B (marked follicular activity, but no luteal function), 12 women Type C (normal follicular activity, followed by insufficient luteal function) and 13 women Type D (apparently normal follicular and luteal activity). The CL were incubated in Eagle's medium with and without stimulation by human chorionic gonadotrophin (HCG) for 2 and 4 h. In the untreated women, P and E2 production increased significantly with both incubation time and stimulation by HCG throughout the luteal phase, except in the late luteal phase (LH +12 to menses) where P increased (P less than 0.01) only after 4 h stimulation by HCG. The maximal production of P was found after 4 h incubation with HCG stimulation of CL tissue in the early-mid luteal phase (LH +4 to +7).(ABSTRACT TRUNCATED AT 250 WORDS)  相似文献   
53.
放疗中呼吸引起的组织深度波动对吸收剂量的影响   总被引:15,自引:13,他引:2       下载免费PDF全文
目的研究放疗中呼吸引起的组织深度波动对吸收剂量的影响。方法在不同能量、组织深度波动幅度、呼吸频率及平均测量深度时,分别用研制的能模拟组织深度波动的辐射剂量测量水箱进行测量,以获得“组织深度波动因子”(Fdw)进行比较。结果组织深度波动确实对实际吸收剂量有影响,而且组织深度波动幅度、呼吸频率及射线能量越大,Fdw值越小,即对吸收剂量的影响越大,而Fdw与平均测量深度无关。结论放疗中必须根据患者的呼吸频率、所用射线类型及呼吸引起的组织深度波动幅度用Fdw对肿瘤或组织的实际吸收剂量进行修正,以提高疗效。  相似文献   
54.
Summary Intravenously admistered iodinated contrast media have been demostrated, since early experience with computed tomography of the brain, to improve clinical value of the procedure for detecting intracranial lesions. There is no universal agreement about the amount and the method of administration of the contrast medium. Many authors maintain that the use of large doses gives better results for the diagnosis of tumors and metastases. The purpose of this paper is to evaluate the tolerance of iopamidol administered by rapid intravenous infusion in a large number of patients undergoing contrast enhanced computed tomography to detect brain metastases. The authors examined 969 consecutive adult patients suffering from lung cancer, brain metastases have been detected in 17% of cases. Adverse reactions to contrast media occurred in 3 patients. Non ionic contrast media are recommended in this diagnostic procedure.  相似文献   
55.
新疆核试验场周围土壤中90Sr137Cs水平   总被引:1,自引:0,他引:1       下载免费PDF全文
用放射化学分析方法,对新疆核试验场周围10个调查区和远离核试验场位于上风向的5个对照区采取的土壤样品进行了90Sr、137Cs分析测定。核试验场周围调查区土壤中90Sr累积平均沉降量为1.5×103Bqm-2,137Cs为4.9×103Bqm-2;对照区90Sr累积平均沉降量为1.3×103Bqm-2,137Cs为3.9×103Bqm-2。调查区和对照区表层土壤中州90Sr,137Cs放射性平均水平无显著性差异。通过估算得出了调查区90Sr、137Cs对居民产生约定有效剂量当量分别为78.3μSv(集体剂量当量负担为23.9人·sv)和270μSv(集体剂量当量负担为82.3人·sv),对照区分别为70.5μSv,(集体剂量当量负担为14.1人·sv)和220μSv(集体剂量当量负担为14.1人·sv)。两个地区居民受到来自核试验产生的90Sr和137Cs给予人体的内照射剂量当量负担基本上是一样的。可认为90Sr、137Cs对新疆核试验场周围没有造成严重的局部污染。对居民的身体健康不致于产生不良影响。  相似文献   
56.
ABSTRACT An ultrasensitive thyrotropin (TSH) assay was used to determine how many of 65 patients with primary hypothyroidism on thyroxine (T4) replacement therapy had suppressed serum TSH. In 13 patients (20%) TSH levels ≤0.1 mlU/l were found, indicating an overdose of thyroxine. After correction of the dose, 48 patients had normal TSH values. Their mean dose of thyroxine was 119 μg/24 hours, and the appropriate replacement dose tended to decline with advancing age. The serum level of thyroid hormones during replacement therapy with thyroxine very imperfectly reflected serum TSH values. It is concluded that overdose of thyroxine is common when suppressed serum TSH is used as an end point. Biochemical follow-up of replacement therapy with thyroxine in primary hypothyroidism therefore requires the use of an ultrasensitive TSH assay in order to detect such suppression. Serum levels of thyroxine or triiodothyronine (T3) during thyroxine therapy are poor indicators of pituitary TSH secretion and are therefore not useful as parameters of adequate thyroxine dosage.  相似文献   
57.
Objective To study the altered radiobiological effect of simulative intensity-modulated radiotherapy (SIMR) in cultured human nasopharyngeal carcinoma (NPC) cells and the related mechanism. Methods Single cell suspension of exponentially growing CNE-2 cells, a poor differentiated NPC cell line, was seeded and cultured for 12 hours, then the cells were irradiated in two different models by 6 MV X-ray beams at 3 Gy/min. In single fraction irradiation (SFR) model, cells were irradiated a single fraction of 0, 2, 4, 6 or 8 Gy within 0 to 3 minutes. In S1MR model, cells were irradiated 0, 2, 4, 6 or 8 Gy in 5 frac-tions with interval of 8.0-8.5 minutes between. Clonogenic assay was performed to determine the radiosen-sitivity. Cellular apoptosis was measured by flow cytometry. RT-PCR was used to detect mRNA expressions of Bax and Bcl-2, Respectively. Results Compared with SFR group, the survival fraction in SIMR group was higher at all the dose levels. The values of α, β, D0 and Dq were higher in SIMR group than in SFR group. At dose levels of 2 Gy, 4 Gy and 6 Gy, The early and late apoptotic cells in SIMR group were lower than in SFR group (21.20%: 15.89%, F=18.51, P=0.020;13.00%: 10.20, F=15.67, P=0.040).The mRNA expression of Bax was upregulated in a dose-dependent manner in the both groups. Compared with SFR group, the mRNA expression of Bax in SIMR group was lower at all the dose levels (Mean value of 76.75% : 62.50%, F =36.57, P =0.000). Bcl-2 mRNA expression at every dose level had no significant difference between the two groups (Mean value of 29.25% : 29.75%, F=0.74, P=0.800). Conclusions Prolonged delivery time in SIMR model can decrease the radiobiological effects.  相似文献   
58.
单次静注爱肌松(0.3mg·kg-1,对照组)于3.17±0.81分钟(x±s)可获得满意的气管插管条件。预注组(10例)首次量0.27mg·kg-1于预注剂量(0.03mg·kg-1)后5分钟给予,可使爱肌松的起效时间缩短至0.93±0.17分钟(P<0.001),TOF无反应期、25%和90%恢复时间两组无显著差别(P>0.25)。全部病例均获得了良好的气管插管条件,预注的优点还在于能评估患者对所选用非去极化肌松药的敏感性。预往后TOF肌电图T1抑制>10%较无明显TOF抑制者肌松恢复时间显著延长(P<0.05)。同时发现吸入安氟醚可使爱肌松作用时效延长。  相似文献   
59.
放射性碘在大鼠甲状腺内的滞留模式及剂量估算   总被引:2,自引:0,他引:2       下载免费PDF全文
为确定放射性碘在甲状腺内滞留模式,观察甲状腺吸收放射性碘后的生物效应,进而评价其辐射危害。方法利用活体测量方法,直接测量两个不同年龄组大鼠甲状腺内131Ⅰ的代谢参数。对测量数据进行处理后得到了大鼠甲状腺内131Ⅰ的滞留函数为三指数项函数。结果利用所得三指数项滞留函数的准确方法进行剂量估算,所得的两组动物的甲状腺平均累积吸收剂量分别为7.7Gy和11.5Gy,而一般方法算得的大鼠甲状腺的平均累积吸收剂量比用准确方法高估了66%~91%。结论由于准确方法考虑到影响估算甲状腺所受剂量的一些因素,故可相对准确地反映了131Ⅰ所致不同年龄大鼠甲状腺的吸收剂量。  相似文献   
60.
本文介绍了用实验方法研究不同管电压, 钢板厚度与散射线之间的关系.结果表明, 透射比随管电压升高而增加, 并随钢板厚度增加而下降;散射比随散射角的增大而逐渐下降, 至180°时为最低值。此研究为X射线探伤作业的辐射防护提供了依据。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号